Compounds > sorafenib
Page last updated: 2024-09-05

sorafenib and dorsomorphin

sorafenib has been researched along with dorsomorphin in 3 studies

Compound Research Comparison

Studies
(sorafenib)		Trials
(sorafenib)		Recent Studies (post-2010)
(sorafenib)		Studies
(dorsomorphin)		Trials
(dorsomorphin)		Recent Studies (post-2010) (dorsomorphin)
6,5207305,2513631259

Protein Interaction Comparison

ProteinTaxonomysorafenib (IC50)dorsomorphin (IC50)
Bone morphogenetic protein receptor type-1BHomo sapiens (human)0.351
5'-AMP-activated protein kinase subunit beta-2Homo sapiens (human)0.1355
Tyrosine-protein kinase LckHomo sapiens (human)0.016
Tyrosine-protein kinase YesHomo sapiens (human)0.1128
Platelet-derived growth factor receptor betaHomo sapiens (human)0.1359
Bone morphogenetic protein 4Homo sapiens (human)0.43
Proto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)0.002
Vascular endothelial growth factor receptor 1 Homo sapiens (human)0.011
Ephrin type-A receptor 2Homo sapiens (human)0.011
Vascular endothelial growth factor receptor 2Homo sapiens (human)0.1089
Receptor-type tyrosine-protein kinase FLT3Homo sapiens (human)0.001
Bone morphogenetic protein receptor type-1AHomo sapiens (human)0.095
TGF-beta receptor type-1Homo sapiens (human)2.6019
Serine/threonine-protein kinase receptor R3Homo sapiens (human)0.1063
TGF-beta receptor type-2Homo sapiens (human)0.1029
Dual specificity protein kinase CLK2Homo sapiens (human)0.1359
5'-AMP-activated protein kinase subunit gamma-1Homo sapiens (human)0.1358
5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)0.1355
Activin receptor type-1Homo sapiens (human)0.1188
5'-AMP-activated protein kinase catalytic subunit alpha-1Homo sapiens (human)0.1355
Bone morphogenetic protein receptor type-2Homo sapiens (human)0.074
Ribosomal protein S6 kinase alpha-1Homo sapiens (human)0.21
MAP kinase-interacting serine/threonine-protein kinase 1Homo sapiens (human)0.011
5'-AMP-activated protein kinase subunit gamma-3Homo sapiens (human)0.1355
5'-AMP-activated protein kinase subunit gamma-2Homo sapiens (human)0.1355
5'-AMP-activated protein kinase subunit beta-1Homo sapiens (human)0.1522

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Alessi, DR; Arthur, JS; Bain, J; Cohen, P; Elliott, M; Hastie, CJ; Klevernic, I; McLauchlan, H; Plater, L; Shpiro, N1
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ1
Caballero, E; García-Cárceles, J; Gil, C; Martínez, A1

Reviews

1 review(s) available for sorafenib and dorsomorphin

ArticleYear
Kinase Inhibitors as Underexplored Antiviral Agents.
    Journal of medicinal chemistry, 2022, 01-27, Volume: 65, Issue:2

    Topics: Animals; Antiviral Agents; Drug Repositioning; Humans; Protein Kinase Inhibitors; Virus Diseases; Viruses

2022

Other Studies

2 other study(ies) available for sorafenib and dorsomorphin

ArticleYear
The selectivity of protein kinase inhibitors: a further update.
    The Biochemical journal, 2007, Dec-15, Volume: 408, Issue:3

    Topics: Amino Acid Sequence; Animals; Cell Line; Drug Design; Enzyme Activation; Humans; Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Recombinant Proteins; Spodoptera

2007
Identification of potent Yes1 kinase inhibitors using a library screening approach.
    Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15

    Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship

2013